Djurstudier för att utvärdera elektroterapier

Göteborgs universitet awarded a framework agreement to Truly Labs AB on 22 April 2026 for conducting animal studies to evaluate electrotherapy treatments, valued at 2,000,000 SEK. The scope encompasses preclinical tumor studies in mice, particularly syngeneic tumor models, to assess tumor growth, metastatic spread, immune system engagement, treatment tolerability, and molecular responses to electroporated therapies, with provision for the buyer's researchers to participate in the in vivo studies on-site.